by Jordana Choucair | Mar 22, 2022 | D.C. News
The White House again urged Congress to allocate $22.5 billion in supplemental COVID-19 aid without offsets. According to the administration, it has about $300 billion in unspent COVID-19 funding, of which $240 billion is fully and publicly allocated, including $105...
by Jordana Choucair | Mar 22, 2022 | Inequities and SDOH
Liz Fowler, director of the Center for Medicare and Medicaid Innovation (CMMI), said health care organizations participating in new value-based payment models will be required to create health equity plans outlining how they will serve underserved patients and curb...
by Jordana Choucair | Mar 22, 2022 | Life Sciences
The Food and Drug Administration (FDA) is ramping up in-person inspections of drug and device manufacturing facilities that were delayed during the pandemic. The FDA said it plans to return to a “normal cadence” next month for inspections overseas, where...
by Jordana Choucair | Mar 22, 2022 | Life Sciences
Pfizer Inc. said it struck a deal to sell up to 4 million courses of its COVID-19 antiviral pill at a “not-for-profit price” to the United Nations Children’s Fund, which will distribute the treatment to 95 lower-income countries. The drugmaker will...
by Jordana Choucair | Mar 22, 2022 | M&A
Three kidney care providers — Fresenius Health Partners, Cricket Health, and InterWell Health — announced they plan to merge in deal valued at $2.4 billion. The new value-based care company will focus on services for the earlier stages of kidney disease and will...
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
Allergan and Teva Pharmaceutical reached a $107 million settlement with the state of Rhode Island over their alleged roles in fomenting the U.S. opioid crisis. Under the deal, Teva will pay $21.5 million over 13 years and supply the state with two medicines to combat...
Recent Comments